Can PSMA-Targeting PET/CT Be a Valuable Instrument to Assess the Presence of Brain Metastases in Lung Cancer Patients?: A Case Report

From the ∗Nuclear Medicine Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza, University of Turin

†Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS

‡Department of Neuroradiology, GCS-fMRI, Koelliker Hospital and Department of Psychology, University of Turin

§Koelliker Hospital, Turin

∥Oncology Medicine Unit, Department of Medical Sciences, AOU San Luigi Gonzaga, University of Turin, Orbassano, Italy

Received for publication November 14, 2022; revision accepted March 10, 2023.

Conflicts of interest and sources of funding: none declared.

Correspondence to: Sara Dall'Armellina, MD, Nuclear Medicine Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza, University of Turin, Molinette, Corso Bramante 88, 10126, Turin, Italy. E-mail: [email protected].

留言 (0)

沒有登入
gif